LS11-006 Reinhard Kirnbauer (Medical University Vienna) Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Duration: 60 months, Funding volume: € 800,000
Reporting from older projects, calls opened before May 2022: funding.wwtf.at
All other reporting and contracting, please refer to funding.wwtf.at
JPETo™ CMS Login
Your login is temporarily disabled.
We use cookies on our website. Some of them are technically necessary, while others help us to improve this website or provide additional functionalities. Further information